Min Lu group (Min Lu laboratory)Shanghai Institute of Hematology, Ruijin Hospital,
Shanghai Jiao Tong University School of Medicine
State Key Laboratory of Medical Genomics
1、Lu, Min; Wu, Jiale; Song, Huaxin. PANDA as a novel therapeutic, PCT/CN2018/085190. The patent has entered China (2020071600684380), US (16959906), EU (EP18898022.1), JP (3148-PCT-JP), AU (2018399726), and CA(0146523-00002).
2、Lu, Min; Wu, Jiale; Song, Huaxin. mp53 rescue compounds and methods of treating a p53 disorder, PCT/CN2019/070117. The patent has entered China (2020071600808010), US(16959894), EU (EP19736093.6), JP (3147-PCT-JP), AU (2019205062), and CA(0146523-00001).
3、Lu, Min; Liang, Ying; Xiao, Shujun; Song, Huaxin. Dual-specificity p53 rescue compound and method of use. 202110659536.4.
4、Lu, Min; Song, Huaxin. A method to screen p53-mutant cancer patients that are applicable for the p53 rescue drugs. 202110659578.8.
5、Lu, Xin; Lu, Min. iASPP phosphorylation and metastatic potential. WIPO, WO 2013/131019 A1